How much does a box of genuine Enasidenib cost?

Enasidenib is an oral small molecule IDH2 inhibitor that was first developed and approved by overseas pharmaceutical companies. It is mainly used to treat relapsed or refractory acute myeloid leukemia (AML), especially patients with IDH2 gene mutations. Such patients often have limited efficacy in traditional chemotherapy. Ensidipine directly inhibits the IDH2 mutant protein and reduces the production of oncogenic metabolites, thereby improving hematopoietic differentiation disorders and bringing new hope for survival to many AML patients. Due to its precise targeting mechanism, the drug has been included in many international treatment guidelines and has become an important treatment option for IDH2-mutated AML.

However, the accessibility of ensidipine remains a real issue for domestic patients. At present, the original version of this drug has not yet been officially launched in mainland China, so domestic patients cannot purchase the drug through regular hospital channels. According to overseas public information, the original drug of ensidipine is relatively expensive. Taking the common specifications of 50 mg 30 tablets and 100 mg 30 tablets as examples, the price of each box is often more than 300,000 yuan, and is affected by factors such as exchange rate fluctuations and import channels. The overall cost is extremely high. This imposes a considerable financial burden on patients taking long-term medication, especially leukemia patients who require maintenance treatment.

Fortunately, more affordable generic drugs have gradually appeared in some overseas countries and regions. For example, in Laos, generic ensidipine drugs in 50mg*30 tablets have been produced, and the price per box is only about RMB 1,000. Although there is a huge price difference, the active ingredients of generic drugs are basically the same as those of the original drugs, and there is no essential difference in the treatment mechanism, which provides new medication options for more patients. It should be noted that the quality control, production standards and source channels of generic drugs require patients and family members to be particularly careful to avoid affecting the efficacy due to irregular drug purchase.

Reference materials:https://www.idhifa.com/